Monitoring brain health to detect Alzheimer's disease risk
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
This study is looking for new, easier ways to spot the risk of Alzheimer's disease using digital tools, so that people can be checked for brain health without needing costly tests, helping to catch any issues earlier, even before symptoms show up.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10883884 on NIH RePORTER |
What this research studies
This research focuses on improving the detection of Alzheimer's disease (AD) risk by utilizing digital technologies to monitor brain health. Instead of relying on expensive and invasive methods like PET scans or cerebrospinal fluid analysis, the study aims to identify digital biomarkers that can indicate changes related to AD. By analyzing data from participants in the Framingham Heart Study, the research seeks to develop a more accessible and scalable approach to detect Alzheimer's risk earlier, potentially before symptoms appear.
Who could benefit from this research
Good fit: Ideal candidates for this research include middle-aged individuals participating in the Framingham Heart Study who may be at risk for Alzheimer's disease.
Not a fit: Patients who are not part of the Framingham Heart Study or those who do not have risk factors for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of Alzheimer's disease, allowing for timely interventions that may slow or prevent disease progression.
How similar studies have performed: Other research has shown promise in using digital technologies for health monitoring, indicating that this approach could be a significant advancement in Alzheimer's disease detection.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Au, Rhoda — Boston University Medical Campus
- Study coordinator: Au, Rhoda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.